Delivery Order SPE2DR25D1022-SPE2DR26FQS1F
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,616.17 by the Defense Logistics Agency on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,458.62 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $5,731.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,726.80 to supply Arimidex 1 mg tablets in a 30-count package. The order, issued on December 5, 2025, with completion by December 8, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract was awarded without set-aside provisions through open competition. The place of performance is...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQS1FDelivery Order
The Defense Logistics Agency awarded a $5,731.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent success in competitive federal procurement, coupled with this substantial IDC, positions the company to fulfill ongoing pharmaceutical requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/14/25 |